Pharmacologically Active Drug Metabolites: Therapeutic and Toxic Activities, Plasma and Urine Data in Man, Accumulation in Renal Failure

No abstract is available for this paper.

• Publication year

  1976

• Venue

  Clinical Pharmacokinetics

• Publication date

  1976-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.2165/00003088-197601060-00003PMID 799549
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• N-hydroxylation of 4,4′-diaminodiphenylsulphone (Dapsone) by liver microsomes, and in dogs and humans

  2004cited by this paper
• Isolation and identification of morphine 3- and 6-glucuronides, morphine 3,6-diglucuronide, morphine 3-ethereal sulfate, normorphine, and normorphine 6-glucuronide as morphine metabolites in humans.

  1977cited by this paper
• Accumulation of normeperidine, an active metabolite of meperidine, in patients with renal failure of cancer.

  1977cited by this paper
• Renal Failure, Drug Pharmacokinetics and Drug Action

  1976cited by this paper
• Adriamycin metabolism in man. Evidence from urinary metabolites.

  1976cited by this paper
• Adriamycin Metabolism in Man

  1976cited by this paper
• The Pharmacological Basis of Therapeutics

  1976cited by this paper
• Antiarrhythmic efficacy of N‐acetylprocainamide in patients with premature ventricular contractions

  1976cited by this paper
• Pharmacokinetics of acetaminophen elimination by anephric patients.

  1976cited by this paper
• Antiepileptic Drugs: Biotransformation, Metabolism, and Serum Half‐Life

  1975cited by this paper
• Quantitative determination of thioridazine and nonconjugated thioridazine metabolites in serum and urine of psychiatric patients.

  1975cited by this paper
• Disposition of acetylmethadol in relation to pharmacologic action

  1975cited by this paper
• Clofibrate-induced muscle damage in patients with chronic renal failure.

  1975cited by this paper
• Biotransformation of Drugs to Pharmacologically Active Metabolites

  1975cited by this paper
• Determination of trichloroethanol at therapeutic and overdose levels in blood and urine by electron capture gas chromatography.

  1975cited by this paper
• An open study of mesoridazine (Serentil) in chronic schizophrenics.

  1975cited by this paper
• Daunorubicin metabolites in human urine.

  1975cited by this paper
• Plasma concentration of α-methyldopa and sulphate conjugate after oral administration of methyldopa and intravenous administration of methyldopa and methyldopa hydrochloride ethyl ester

  1975cited by this paper
• The Bioavailability of Meperidine Using Urine Assays for Meperidine and Normeperidine

  1975cited by this paper
• Critical compilation of terminal half-lives, percent excreted unchanged, and changes of half-life in renal and hepatic dysfunction for studies in humans with references

  1975cited by this paper
• Pharmacokinetics and metabolism of lidocaine in patients with renal failure

  1975cited by this paper
• Concepts in Biochemical Pharmacology

  1975cited by this paper
• Leukaemoid reactions associated with fulminating ulcerative colitis

  1975cited by this paper
• First‐pass metabolism of imipramine in man

  1975cited by this paper
• The role of the kidney in the elimination of cephapirin in man

  1975cited by this paper
• Simultaneous determination of acetylmethadol and its active riotransformation products in human biofluids.

  1975cited by this paper
• Disposition of beta-methyldigoxin in man.

  1975cited by this paper
• Plasma kinetics of carbamazepine and its epoxide metabolite in man after single and multiple doses

  1975cited by this paper
• Acetylation of procainamide in man and its relationship to isonicotinic acid hydrazide acetylation phenotype

  1975cited by this paper
• Proceedings: The relationship between fenfluramine and norfenfluramine blood levels and anoretic activity in the rat.

  1975cited by this paper
• Stereospecific synthesis of the 6beta-hydroxy metabolites of naltrexone and naloxone.

  1975cited by this paper
• Increased incidence of isoniazid hepatitis in rapid acetylators: possible relation to hydrazine metabolites

  1975cited by this paper
• A GLC method for estimation of chlorophenoxyisobutyric acid in plasma. Pharmacokinetics of a single oral dose of clofibrate in man

  1975cited by this paper
• Polymorphic acetylation of procainamide in man

  1975cited by this paper
• Pharmacokinetic study of a peripheral analgesic, floctafenin, in man, mouse, rat, and dog.

  1975cited by this paper
• Pharmacological activity, metabolism, and pharmacokinetics of glycinexylidide

  1975cited by this paper
• Fenfluramine and methylcellulose in the treatment of obesity: the relationship between plasma drug concentrations and therapeutic efficacy.

  1975cited by this paper
• Concentration of glutethimide and associated compounds in huamn serum and cerebrospinal fluid after drug overdose.

  1974cited by this paper
• Methods of Analysis of Anti-Epileptic Drugs

  1974cited by this paper
• Adriamycin and daunorubicin disposition in the rabbit.

  1974cited by this paper
• Renal failure and the action of drugs.

  1974cited by this paper
• Plasma concentrations of diazepam and of its metabolite N‐desmethyldiazepam in relation to anxiolytic effect

  1974cited by this paper
• Gas-chromatographic simultaneous analysis for glutethimide and an active hydroxylated metabolite in tissues, plasma, and urine.

  1974cited by this paper
• Pharmacokinetics and biotransformation of chlorpropamide in the rat and dog.

  1974cited by this paper
• Renal failure and the action of drugs.

  1974cited by this paper
• Effects of 1,25-dihydroxycholecalciferol on calcium absorption, muscle weakness, and bone disease in chronic renal failure.

  1974cited by this paper
• Metabolism and excretion of digitoxin in man

  1974cited by this paper
• Structure-activity relationships in man of cannabis constituents, and homologs and metabolites of delta9-tetrahydrocannabinol.

  1974cited by this paper
• The etiology of methoxyflurane nephrotoxicity.

  1974cited by this paper
• Determination of chlordiazepoxide hydrochlor ide (Librium) and its major metabolites in plasma by differential pulse polarography.

  1974cited by this paper
• Central nervous system effects and metabolic disposition of a glycol metabolite of propranolol.

  1974cited by this paper
• The urinary excretion profile of naltrexone and metabolites in man.

  1974cited by this paper
• Spectrofluorodensitometric determination of flurazepam and its major metabolites in blood.

  1974cited by this paper
• A guide to drug therapy in renal failure.

  1974cited by this paper
• Plasma levels of methsuximide and N‐desmethylmethsuximide during methsuximide therapy

  1974cited by this paper
• Identification and activity of the hydroxy metabolite that accumulates in the plasma of humans intoxicated with glutethimide.

  1974cited by this paper
• Plasma half‐lives, plasma metabolites and anticoagulant efficacies of the enantiomers of warfarin in man *

  1973cited by this paper
• Methoxyflurane nephrotoxicity. A study of dose response in man.

  1973cited by this paper
• Metabolic profile of a new immunosuppressive agent, oxisuran: binding, RE stimulation, drug interaction.

  1973cited by this paper
• Editorial: Role of the kidney in the metabolism of calciferol (vitamin D).

  1973cited by this paper
• The convulsant potency of lidocaine and its N-dealkylated metabolites.

  1973cited by this paper
• Ethynodiol diacetate metabolites in human plasma.

  1973cited by this paper
• Editorial: Role of the kidney in the metabolism of calciferol (vitamin D).

  1973cited by this paper
• Methsuximide overdose. Delayed onset of profound coma.

  1973cited by this paper
• Studies on the metabolism in man of oxisuran, a differential immunosuppressive drug

  1973cited by this paper
• The possible role of metabolites in therapeutic response to chlorpromazine treatment

  1973cited by this paper
• Quantitative determination of imipramine and desipramine in human blood plasma by direct densitometry of thin‐layer chromatograms

  1973cited by this paper
• Ion-pair extraction and high-speed liquid chromatography of cephalothin and deacetylcephalothin in human serum and urine.

  1973cited by this paper
• Metabolism and pharmacokinetics of naloxone.

  1973cited by this paper
• Identification of glycinexylidide in patients treated with intravenous lidocaine

  1973cited by this paper
• Warfarin metabolites: the anticoagulant activity and pharmacology of warfarin alcohols.

  1973cited by this paper
• Studies of the metabolism of dapsone in man and experimental animals: formation of N-hydroxy metabolites.

  1973cited by this paper
• Diazepam metabolism during chronic medication unbound fraction in plasma, erythrocytes and urine.

  1973cited by this paper
• Difenoxine (R 15403), the active metabolite of diphenoxylate (R 1132). 6. Absorption, excretion and metabolism in man.

  1972cited by this paper
• Glutethimide intoxication: plasma levels of glutethimide and a metabolite in humans, dogs and rats.

  1972cited by this paper
• Daunorubicin metabolism in acute nonlymphocytic leukemia

  1972cited by this paper
• Conjugation of methyldopa in renal failure.

  1972cited by this paper
• Metabolites of probenecid. Chemical, physical, and pharmacological studies.

  1972cited by this paper
• Effect of various chlorpromazine metabolites on amphetamine-induced stereotyped behaviour in the rat.

  1972cited by this paper
• Difenoxine (R 15403), the active metabolite of diphenoxylate (R 1132). 5. Clinical comparison of difenoxine and diphenoxylate in volunteers and in patients with chronic diarrhea. Double-blind cross-over assessments.

  1972cited by this paper
• Metabolism of oral contraceptives. I. Metabolism of ethynodiol diacetate in women.

  1972cited by this paper
• Propranolol metabolism in man and dog: mass spectrometric identification of six new metabolites.

  1972cited by this paper
• HYPOTENSIVE EFFECT OF METHYLDOPA IN RENAL FAILURE ASSOCIATED WITH HYPERTENSION

  1972cited by this paper
• Glutethimide intoxication: plasma levels of glutethimide and a metabolite in humans, dogs and rats.

  1972cited by this paper
• Pharmacokinetics and biotransformation of chlorpropamide in man

  1972cited by this paper
• Mass spectrometric characterization of carbamazepine-10,11-epoxide, a carbamazepine metabolite isolated from human urine.

  1972cited by this paper
• Drug therapy. Serum drug concentrations as therapeutic guides.

  1972cited by this paper
• Action of 1,25-dihydroxycholecalciferol, a potent, kidney-produced metabolite of vitamin D, in uremic man.

  1972cited by this paper
• Intravenous Injection in Man of Δ9-Tetrahydrocannabinol and 11-OH-Δ9-Tetrahydrocannabinol

  1972cited by this paper
• Norethynodrel metabolites in human plasma and urine.

  1972cited by this paper
• Metabolic disposition of primidone and its metabolites in epileptic subjects after single and repeated administration

  1972cited by this paper
• Effect of Hemodialysis and Renal Failure on Serum and Urine Concentrations of Cephapirin Sodium

  1972cited by this paper
• The tissue distribution, metabolism and excretion of lidocaine in rats, guinea pigs, dogs and man.

  1972cited by this paper
• Simultaneous determination of trimethadione and its metabolite, dimethadione, by gas-liquid chromatography.

  1971cited by this paper
• A specific gas-chromatographic method for the measurement of "steady-state" plasma levels of amitriptyline and nortriptyline in patients.

  1971cited by this paper
• 2 – β-Adrenergic Blocking Agents

  1971cited by this paper
• The acute antiarrhythmic and toxic effects in mice and dogs of 2-ethylamino-2',6-'acetoxylidine (L-86), a metabolite of lidocaine.

  1971cited by this paper
• Renal Function and Drug Action

  1971cited by this paper
• Cephaloglycin and its biologically active metabolite desacetylcephaloglycin.

  1971cited by this paper
• Antihypertensive and noradrenaline‐depleting effects of guanethidine metabolites

  1971cited by this paper

• Neuroprotective properties of Betulin, Betulinic acid, and Ursolic acid as triterpenoids derivatives: a comprehensive review of mechanistic studies

  2023cites this paper
• Contribution analysis of metabolic tissues on systemic exposure of an active metabolite after oral administration of verapamil using a stable isotope-labeled compound.

  2023cites this paper
• Antioxidation and Nrf2-mediated heme oxygenase-1 activation contribute to renal protective effects of hydralazine in diabetic nephropathy.

  2022cites this paper
• Oral and Maxillofacial Surgical Management for the Renal Compromised Patient

  2021cites this paper
• Biologically active metabolites in drug discovery.

  2021cites this paper
• Reactive metabolites of the anticonvulsant drugs and approaches to minimize the adverse drug reaction.

  2021cites this paper
• Synthesis and Biological Evaluation of Amino Acid Based Mutual Amide Prodrugs of Phenytoin as Anticonvulsant Agents.

  2020cites this paper
• Revisited: Therapeutic and toxic blood concentrations of more than 1100 drugs and other xenobiotics

  2020cites this paper
• Role of Metabolites in Bioequivalency Assessment

  2019cites this paper
• Hydralazine improves ischemia-induced neovasculogenesis via xanthine-oxidase inhibition in chronic renal insufficiency.

  2019cites this paper
• Pharmacokinetics in children with chronic kidney disease

  2019cites this paper
• Application of Aluminum Hydroxide for Improvement of Label-Free SERS Detection of Some Cephalosporin Antibiotics in Urine

  2019cites this paper
• Brush Up Your Medicine

  2018cites this paper
• Dental implant treatment for renal failure patients on dialysis: a clinical guideline

  2017cites this paper
• Drug Metabolism in Preclinical Drug Development: A Survey of the Discovery Process, Toxicology, and Computational Tools.

  2017cites this paper
• Increase in the systemic exposure of primary metabolites of Midazolam in rat arising from CYP inhibition or hepatic dysfunction.

  2017cites this paper
• PBPK Modeling to Estimate Metabolite Formation From First-Pass Organs: Intestine and Liver

  2017cites this paper
• A Pharmacokinetic Modeling Approach to Predict the Contribution of Active Metabolites to Human Efficacious Dose

  2016cites this paper
• Urinary Tract Infection in Chronic Renal Insufficiency: A Case Study

  2016cites this paper
• OPIOIDS, SUBSTANCE ABUSE & ADDICTIONS SECTION Review Articles Interpretation of Urine Drug Testing in Pain Patients

  2016cites this paper
• Noscapine recirculates enterohepatically and induces self-clearance.

  2015cites this paper
• Options and Problems of Drug Application in Patients with Advanced Cancer

  2015cites this paper
• Predicting Toxic Effects of Metabolites

  2014cites this paper
• Dosing errors in prescribed antibiotics for older persons with CKD: a retrospective time series analysis.

  2014cites this paper
• Renal Disposition of Drugs and Translation to Dosing Strategies

  2013cites this paper
• Pharmacologically Active Drug Metabolites: Impact on Drug Discovery and Pharmacotherapy

  2013cites this paper
• Significance of Biotransformation in Drug Discovery and Development

  2013cites this paper
• Translational Drug Discovery Research: Integration of Medicinal Chemistry, Computational Modeling, Pharmacology, ADME, and Toxicology

  2012cites this paper
• Therapeutic and toxic blood concentrations of nearly 1,000 drugs and other xenobiotics

  2012cites this paper
• Table 2 List of prescription and illicit drugs commonly used in the pain population

  2012cites this paper
• Interpretation of urine drug testing in pain patients.

  2012cites this paper
• The Pharmacological Role of the Kidney

  2012cites this paper
• Drug Dosing in Patients With Impaired Renal Function

  2009cites this paper
• A study of the pharmacokinetic interactions of the direct renin inhibitor aliskiren with allopurinol, celecoxib and cimetidine in healthy subjects

  2008cites this paper
• Chapter 91 – Drug Dosing in Renal Failure

  2008cites this paper
• CHAPTER 98 – Disposition and Dose Requirements of Drugs in Renal Insufficiency

  2008cites this paper
• Unadjusted medication dose in patients with chronic kidney disease.

  2008cites this paper
• Formed and preformed metabolites: facts and comparisons

  2008cites this paper
• Drug dosing adjustments in patients with chronic kidney disease.

  2007cites this paper
• Meperidine and skin surface warming additively reduce the shivering threshold: a volunteer study

  2007cites this paper
• Role of Metabolites in Bioequivalence Assessment

  2007cites this paper
• Effects of allopurinol treatment on the progression of chronic nephritis in Canine leishmaniosis (Leishmania infantum).

  2006cites this paper
• Drug dosing in chronic kidney disease.

  2005influential citation
• The metabolic disposition of flucloxacillin in patients with impaired kidney function

  2004cites this paper
• The Role of Metabolites in Bioequivalency Assessment. I. Linear Pharmacokinetics without First-Pass Effect

  2004cites this paper
• HPLC Determination of Lignocaine and Its Metabolite Xylidine in Aqueous Humor

  2003cites this paper
• Therapeutic and toxic blood concentrations of more than 800 drugs and other xenobiotics.

  2003cites this paper
• Active drug metabolites in drug development.

  2003cites this paper
• Pharmacological aspects of nephrotoxicity

  2003cites this paper
• A randomised, blinded, placebo-controlled clinical trial with allopurinol in canine leishmaniosis.

  2001cites this paper
• Principles of drug dosing in renal failure

  1998cites this paper
• Therapeutic and toxic blood concentrations of more than 500 drugs.

  1997cites this paper
• Physiological disposition of L-663,581, a partial agonist of the benzodiazepine receptor, in laboratory animals.

  1994cites this paper
• [A compilation of therapeutic and toxic plasma drug concentrations].

  1994cites this paper
• Analysis of pharmacokinetic-dynamic interrelations with special reference to applications in cardiovascular clinical pharmacology.

  1994cites this paper
• Methodological approach in the study of anticancer drug metabolism: qualitative considerations.

  1993cites this paper
• Individual Variation in First-Pass Metabolism

  1993cites this paper
• The clinician and therapeutic drug monitoring in the 1990s

  1993cites this paper
• Drug Dosing in Renal Failure

  1992cites this paper
• Biological Rhythms in Hepatic Drug Metabolism and Biliary Systems

  1992cites this paper
• Use of Drugs in Uremia and Dialysis

  1991cites this paper
• Formation of active metabolites of psychotropic drugs. An updated review of their significance.

  1990cites this paper
• 6 – The Impact of Renal Dysfunction on Drug Handling and How to Compensate for It

  1990cites this paper
• Physiological modeling of drug and metabolite: Disposition of oxazepam and oxazepam glucuronides in the recirculating perfused mouse liver preparation

  1990cites this paper
• Formation of Active Metabolites of Psychotropic Drugs

  1990cites this paper
• Drug metabolites in anaesthetic practice--are they important?

  1988cites this paper
• Arzneitherapie bei renaler Insuffizienz

  1988cites this paper
• Renal handling of drugs in renal failure. I: Differential effects of uranyl nitrate- and glycerol-induced acute renal failure on renal excretion of TEAB and PAH in rats.

  1988cites this paper
• Effect of a diffusional barrier to a metabolite across hepatocytes on its kinetics in “enzyme-distributed” models: A computer-aided simulation study

  1987cites this paper
• The use of drugs in renal failure.

  1986cites this paper
• PHARMACOKINETICS, METABOLISM AND ELIMINATION AND THEIR RELATION TO THE EFFECTS AND TOXICITY OF SELECTED DRUGS AND CHEMICALS

  1986cites this paper
• A review of metabolite kinetics

  1985influential citation
• Kidney function and drug action.

  1985cites this paper
• Monitoring Antiepileptic Drug Levels

  1985cites this paper
• β-Adrenoceptor Blocking Agents

  1985cites this paper
• FACTORS CONTRIBUTING TO VARIABILITY IN DRUG PHARMACOKINETICS. IV. RENAL EXCRETION

  1985cites this paper
• Drug metabolite concentration-time profiles: influence of route of drug administration.

  1984cites this paper
• Comparative Electrophysiology of Lorcainide and Norlorcainide in the Dog

  1984cites this paper
• [Drug monitoring in intensive care medicine].

  1984cites this paper
• First-Pass Elimination Basic Concepts and Clinical Consequences

  1984cites this paper
• Importance of metabolites in antiarrhythmic therapy.

  1983cites this paper
• Active metabolites in antiepileptic therapy. Reflections on a pharmacological joker.

  1983cites this paper
• Some Consequences of Drug Choice and Dosage Regimen for Patients with Impaired Kidney Function

  1983cites this paper
• The clinician and therapeutic drug monitoring

  1983cites this paper
• CHAPTER 12 – Metabolic Basis of Target Organ Toxicity

  1983cites this paper
• Pharmacologically Active Metabolites of Drugs and Other Foreign Compounds

  1982cites this paper
• Development of Fluoroimmunoassays for the determination of individual or combined levels of procainamide and N-acetylprocainamide in serum.

  1982cites this paper
• Glucuronidation and disposition of drug glucuronides in patients with renal failure. A review.

  1982cites this paper
• Dosage adjustment in renal insufficiency.

  1982cites this paper
• Rate limiting steps in metabolite kinetics: formation of 5‐acetylaminosalicylate after administration of 5‐aminosalicylate

  1982cites this paper
• Drug Metabolites in Renal Failure

  1981cites this paper
• Drug metabolites in renal failure: pharmacokinetic and clinical implications.

  1981cites this paper
• Drug metabolite kinetics.

  1981cites this paper
• Differences in Kinetic Properties of Drugs: Implications as to the Selection of a Particular Drug for Use in Patients with Renal Failure With Special Emphasis on Antibiotics and β-Adrenoceptor Blocking Agents

  1980cites this paper
• The Effect of Impaired Renal Function on the Plasma Concentration and Urinary Excretion of Metoprolol Metabolites

  1980cites this paper
• Drug Metabolism at Various Ages — Young

  1980cites this paper
• Impact of Active Metabolites on Monitoring Plasma Concentrations of Therapeutic Drugs

  1980cites this paper
• Prenatal and neonatal drug metabolism in man

  1980cites this paper
• Drug therapy in renal failure: dosing guidelines for adults. Part I: Antimicrobial agents, analgesics.

  1980cites this paper
• Prediction of steady-state behavior of metabolite from dosing of parent drug.

  1980cites this paper